Without industry-backed research on statins, for example, doctors might not have all the tools they now use to treat high cholesterol.
According to Kesselheim, there's simply no way for doctors to ignore drug-company-funded trials, because, for better or worse, Big Pharma is underwriting an ever greater percentage of clinical research.